Imagine being told you need surgery for colorectal cancer, a disease that ranks as the third most common cancer globally and the second leading cause of cancer-related deaths. But here's where it gets controversial: what if losing weight before surgery could actually improve your outcomes? New research is challenging conventional wisdom by exploring the safety and feasibility of intentional weight loss in patients with excess weight facing colorectal cancer surgery. And this is the part most people miss—it’s not just about shedding pounds; it’s about potentially reducing surgical risks and improving recovery.
The CARE feasibility trial, a groundbreaking multicenter study, has revealed that a low-energy total diet replacement program before colorectal cancer surgery is not only safe and feasible but also likely cost-effective. This approach involves replacing regular meals with nutritionally complete, low-calorie meal replacements, providing around 800 calories per day, including 76 grams of protein. The program includes personalized support through dietitian consultations and follow-up calls, ensuring participants stay on track.
Here’s the kicker: While preoperative weight loss is well-established in bariatric surgery, its application in colorectal cancer patients has been largely unexplored due to the urgency of treatment. Dimitrios Koutoukidis, PhD, and his team at the University of Oxford, questioned whether patients would even enroll in such a program during the emotionally charged period after a cancer diagnosis. Surprisingly, the trial not only attracted participants but also saw high adherence and retention rates.
The study, conducted across 8 hospitals in England, enrolled 71 participants with a body mass index of 28 or higher. The intervention group followed the low-energy diet replacement program, while the control group received standard care. Results showed that 61% of intervention participants lost at least 5% of their body weight, compared to just 9% in the usual care group. On average, intervention participants lost 6.1 kg more than the control group, with no significant loss of fat-free mass. Even more striking, postoperative symptoms like fecal incontinence and sore skin improved in the intervention group, and there were no serious adverse events related to the program.
But here’s the controversial part: Could this approach become a standard prehabilitation strategy for colorectal cancer patients? While the trial demonstrated safety and feasibility, challenges in recruitment were noted, suggesting that broader implementation may require addressing patient hesitancy or logistical barriers. Additionally, the cost-effectiveness analysis estimated an incremental cost of £7,623 ($10,193.40 USD) per quality-adjusted life-year, raising questions about accessibility and healthcare resource allocation.
As we ponder these findings, it’s worth asking: Should intentional weight loss be integrated into preoperative care for colorectal cancer patients, or is it an unnecessary burden during an already stressful time? What do you think? Share your thoughts in the comments below—this is a conversation that deserves to be heard.
